Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Acosta

Showing results (301-310 of 338) with videos related to

Pageof 34
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 3, 2018
Dolutegravir Plus Lamivudine Maintains Human Immunodeficiency Virus-1 Suppression Through Week 48 in a Pilot Randomized TrialBabafemi O Taiwo, Vincent C Marconi, Baiba Berzins, et al.
Pediatrics|December 13, 2016
Mechanistic Pathways From Early Gestation Through Infancy and NeurodevelopmentSangshin Park, David C Bellinger, Meredith Adamo, et al.
Journal of the Pediatric Infectious Diseases Society|May 26, 2020
Pharmacokinetics and Safety of a Raltegravir-Containing Regimen in Children Aged 4 Weeks to 2 Years Living With Human Immunodeficiency Virus and Receiving Rifampin for TuberculosisPaul Krogstad, Pearl Samson, Edward P Acosta, et al.
The Journal of Infectious Diseases|August 16, 2021
A Phase 1/2 Randomized, Placebo-Controlled Trial of Romidespin in Persons With HIV-1 on Suppressive Antiretroviral TherapyDeborah K McMahon, Lu Zheng, Joshua C Cyktor, et al.
Journal of Medicine and Life|January 25, 2018
Effect of Dialyzable Leukocyte Extract on chronic cervicitis in patients with HPV infectionM P Acosta-Rios, E Sauer-Ramírez, L J Castro-Muñoz, et al.
Infection and Immunity|December 22, 2005
T-helper-2 cytokine responses to Sj97 predict resistance to reinfection with Schistosoma japonicumTjalling Leenstra, Luz P Acosta, Hai-Wei Wu, et al.
The Journal of Infectious Diseases|July 29, 2010
Effect of CYP2B6, ABCB1, and CYP3A5 polymorphisms on efavirenz pharmacokinetics and treatment response: an AIDS Clinical Trials Group studyHeather J Ribaudo, Huan Liu, Matthias Schwab, et al.
Animal Biotechnology|October 6, 2020
Metabolome fingerprints, performance and carcass quality of beef calves supplemented with antibiotic free additiveJefferson R Gandra, Cibeli A Pedrini, Nara R B Cônsolo, et al.
The Journal of Antimicrobial Chemotherapy|January 23, 2019
Dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA <500 000 copies/mL: week 48 outcomes from ACTG 5353Amesika N Nyaku, Lu Zheng, Roy M Gulick, et al.
Breast Cancer Research : BCR|March 5, 2021
An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancerErica M Stringer-Reasor, Jori E May, Eva Olariu, et al.
Pageof 34

Showing results (301-310 of 338) with videos related to

Sort By:
Pageof 34
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 3, 2018
Dolutegravir Plus Lamivudine Maintains Human Immunodeficiency Virus-1 Suppression Through Week 48 in a Pilot Randomized TrialBabafemi O Taiwo, Vincent C Marconi, Baiba Berzins, et al.
Pediatrics|December 13, 2016
Mechanistic Pathways From Early Gestation Through Infancy and NeurodevelopmentSangshin Park, David C Bellinger, Meredith Adamo, et al.
Journal of the Pediatric Infectious Diseases Society|May 26, 2020
Pharmacokinetics and Safety of a Raltegravir-Containing Regimen in Children Aged 4 Weeks to 2 Years Living With Human Immunodeficiency Virus and Receiving Rifampin for TuberculosisPaul Krogstad, Pearl Samson, Edward P Acosta, et al.
The Journal of Infectious Diseases|August 16, 2021
A Phase 1/2 Randomized, Placebo-Controlled Trial of Romidespin in Persons With HIV-1 on Suppressive Antiretroviral TherapyDeborah K McMahon, Lu Zheng, Joshua C Cyktor, et al.
Journal of Medicine and Life|January 25, 2018
Effect of Dialyzable Leukocyte Extract on chronic cervicitis in patients with HPV infectionM P Acosta-Rios, E Sauer-Ramírez, L J Castro-Muñoz, et al.
Infection and Immunity|December 22, 2005
T-helper-2 cytokine responses to Sj97 predict resistance to reinfection with Schistosoma japonicumTjalling Leenstra, Luz P Acosta, Hai-Wei Wu, et al.
The Journal of Infectious Diseases|July 29, 2010
Effect of CYP2B6, ABCB1, and CYP3A5 polymorphisms on efavirenz pharmacokinetics and treatment response: an AIDS Clinical Trials Group studyHeather J Ribaudo, Huan Liu, Matthias Schwab, et al.
Animal Biotechnology|October 6, 2020
Metabolome fingerprints, performance and carcass quality of beef calves supplemented with antibiotic free additiveJefferson R Gandra, Cibeli A Pedrini, Nara R B Cônsolo, et al.
The Journal of Antimicrobial Chemotherapy|January 23, 2019
Dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA <500 000 copies/mL: week 48 outcomes from ACTG 5353Amesika N Nyaku, Lu Zheng, Roy M Gulick, et al.
Breast Cancer Research : BCR|March 5, 2021
An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancerErica M Stringer-Reasor, Jori E May, Eva Olariu, et al.
Pageof 34